(19)
(11) EP 2 209 783 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.06.2016 Bulletin 2016/22

(45) Mention of the grant of the patent:
16.03.2016 Bulletin 2016/11

(21) Application number: 08850085.5

(22) Date of filing: 13.11.2008
(51) International Patent Classification (IPC): 
C07D 471/08(2006.01)
A61P 25/18(2006.01)
 A61K 31/517(2006.01)
(86) International application number:
PCT/EP2008/065436
(87) International publication number:
WO 2009/062988 (22.05.2009 Gazette 2009/21)

(54)

NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINE DERIVATIVES AND THEIR MEDICAL USE

NEUARTIGE 1,4-DIAZA-BICYCLO-[3,2,2]-NONYL-PYRIMIDIN-DERIVATE UND IHRE MEDIZINISCHE VERWENDUNG

NOUVEAUX DÉRIVÉS DE 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINE ET LEUR UTILISATION MÉDICALE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 14.11.2007 DK 200701620
15.11.2007 US 988118 P

(43) Date of publication of application:
28.07.2010 Bulletin 2010/30

(73) Proprietor: Saniona A/S
2750 Ballerup (DK)

(72) Inventors:
  • PETERS, Dan
    DK-2750 Ballerup (DK)
  • TIMMERMANN, Daniel, B.
    DK-2750 Ballerup (DK)
  • NIELSEN, Elsebet, Østergaard
    DK-2750 Ballerup (DK)
  • OLSEN, Gunnar, M.
    DK-2750 Ballerup (DK)
  • DYHRING, Tino
    DK-2750 Ballerup (DK)
  • CHRISTENSEN, Jeppe, Kejser
    DK-2750 Ballerup (DK)
  • REDROBE,John, Paul
    DK-2610 Rødovre (DK)
  • MIKKELSEN, Jens, Damsgaard
    DK-2800 Lyngby (DK)

(74) Representative: Høiberg A/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)


(56) References cited: : 
WO-A-2004/024729
WO-A-2005/074940
 WO-A-2004/029053
WO-A-2005/075482
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).